Antibiotics have made it possible to treat bacterial infections such as meningitis and
bacteraemia that, prior to their introduction, were untreatable and consequently fatal …

Carbapenem is an important therapy for serious hospital‐acquired infections and for the
care of patients affected by multidrug‐resistant organisms, specifically Acinetobacter …

The misuse of antibiotics combined with a lack of newly developed ones is the main
contributors to the current antibiotic resistance crisis. There is a dire need for new and …

Multidrug-resistant bacteria have on overwhelming impact on human health, as they cause
over 670,000 infections and 33,000 deaths annually in the European Union alone. Of these …

Antibiotics are being less effective, which leads to high mortality in patients with infections
and a high cost for the recovery of health, and the projections that are had for the future are …

The emergence of multidrug-resistant (MDR) bacterial infections poses a catastrophic threat
to medicine. The development of phage-based therapy combined with antibiotics might be …

The purpose of this narrative review is to bring together the most recent epidemiologic,
preclinical, and clinical findings to offer our perspective on best practices for managing …

Background The development of vaccines is a promising and cost-effective strategy to
prevent emerging multidrug-resistant (MDR) Acinetobacter baumannii (A. baumannii) …

Acinetobacter spp., the nosocomial pathogen, forms strong biofilms and is resistant to
numerous antibiotics, causing persistent infections. This study investigates the antibacterial …

ABSTRACT In 2017, the World Health Organization (WHO) named A. baumannii as one of
the three antibiotic-resistant bacterial species on its list of global priority pathogens in dire …